We used breast cancer samples of different histological subtypes, as well as DLBCL samples, as a guide to determine primary antibody concentrations and incubation times in order to observe gradients of EZH2 and H3K27 methylation IHC expression [12]. Here, EZH2 is linked to breast cancer.